Chunhao Wang

Chunhao Wang

Auto-generated profile, based on publicly available information

Chunhao Wang

Department of Radiation Oncology Duke University Durham North Carolina USA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2019 in Technology in Cancer Research & Treatment
Verified
Journal Article
Open access
PDF file
CWChunhao Wang
Chunhao Wang
XZXiaofeng Zhu
Xiaofeng Zhu
JHJulian Hong
Julian Hong
DZDandan Zheng
Dandan Zheng
Treatment planning is an essential step of the radiotherapy workflow. It has become more sophisticated over the past couple of decades with the help of computer science, enabling planners to design highly complex radiotherapy plans to minimize the normal tissue damage while persevering sufficient tumor control. As a result, treatment planning has become more labor intensive, requiring hours or even days of planner effort to optimize an individual patient case in a trial-and-error fashion. More recently, artificial intelligence has been utilized to automate and improve various aspects of medical science. For radiotherapy treatment planning, many algorithms have been developed to better support planners. These algorithms focus on automating the planning process and/or optimizing dosimetric trade-offs, and they have already made great impact on improving treatment planning efficiency and plan quality consistency. In this review, the smart planning tools in current clinical use are summarized in 3 main categories: automated rule implementation and reasoning, modeling of prior knowledge in clinical practice, and multicriteria optimization. Novel artificial intelligence–based treatment planning applications, such as deep learning–based algorithms and emerging research directions, are also reviewed. Finally, the challenges of artificial intelligence–based treatment planning are discussed for future works.

15 March 2022 in Medical Physics
Verified
Journal Article
Closed access
ZHZongsheng Hu
Zongsheng Hu
ZYZhenyu Yang
Zhenyu Yang
KLKyle J. Lafata
Kyle J. Lafata
FYFang‐Fang Yin
Fang‐Fang Yin
CWChunhao Wang
Chunhao Wang

10 August 2021 in Medical Physics
Verified
Journal Article
Closed access
PDF file
CWChunhao Wang
Chunhao Wang
KPKyle R. Padgett
Kyle R. Padgett
MSMin‐Ying Su
Min‐Ying Su
EMEric A. Mellon
Eric A. Mellon
DMDanilo Maziero
Danilo Maziero
ZCZheng Chang
Zheng Chang

18 August 2020 in Frontiers in Oncology
Verified
Journal Article
Open access
PDF file
CWChunhao Wang
Chunhao Wang
CLChenyang Liu
Chenyang Liu
YCYushi Chang
Yushi Chang
KLKyle Lafata
Kyle Lafata
YCYunfeng Cui
Yunfeng Cui
FYFang-Fang Yin
Fang-Fang Yin
Purpose: To develop a deep learning-based AI agent, DDD-PIOP (Dose-Distribution-Driven PET Image Outcome Prediction), for predicting 18FDG-PET image outcomes of oropharyngeal cancer (OPC) in response to intensity-modulated radiation therapy (IMRT). Methods: DDD-PIOP uses pre-radiotherapy 18FDG-PET/CT images and the planned spatial dose distribution as the inputs, and it predicts the 18FDG-PET image outcomes in response to the planned IMRT delivery. This AI agent centralizes a customized convolutional neural network (CNN) as a deep learning approach, and it incorporates a few designs to enhance prediction accuracy. 66 OPC patients who received IMRT treatment on a sequential boost regime (2 Gy/daily fraction) were studied for DDD-PIOP development. 61 patients were used for AI agent training/validation, and the remaining five were used as independent tests. To evaluate the developed AI agent’s performance, the predicted mean standardized uptake values (SUVs) of gross tumor volume (GTV) and clinical target volume (CTV) were compared with the ground truth values. Overall SUV distribution accuracy was evaluated by gamma test passing rates under different criteria. Results: The developed DDD-PIOP successfully generated 18FDG-PET image outcome predictions for five test patients. The predicted mean SUV values of GTV/CTV were 3.50/1.41, which were close to the ground-truth values of 3.57/1.51. In 2D-based gamma tests, the average passing rate was 92.1% using 5%/10 mm criteria, which was improved to 95.9%/93.2% when focusing on GTV/CTV regions. 3D gamma test passing rates were 98.7% using 5%/10 mm criteria, and the corresponding GTV/CTV results were 99.8%/99.4%. Conclusion: The reported results suggest that the developed AI agent DDD-PIOP successfully predicted 18FDG-PET image outcomes with high quantitative accuracy. The generated voxel-based image outcome predictions could be used for treatment planning optimization prior to radiation delivery for the best individual-based outcome.

13 May 2022 in Frontiers in Oncology
Verified
Journal Article
Open access
HJHangjie Ji
Hangjie Ji
KLKyle Lafata
Kyle Lafata
YMYvonne Mowery
Yvonne Mowery
DBDavid Brizel
David Brizel
ABAndrea L. Bertozzi
Andrea L. Bertozzi
CWChunhao Wang
Chunhao Wang
Purpose: To develop a method of biologically guided deep learning for post-radiation 18FDG-PET image outcome prediction based on pre-radiation images and radiotherapy dose information.Methods: Based on the classic reaction–diffusion mechanism, a novel biological model was proposed using a partial differential equation that incorporates spatial radiation dose distribution as a patient-specific treatment information variable. A 7-layer encoder–decoder-based convolutional neural network (CNN) was designed and trained to learn the proposed biological model. As such, the model could generate post-radiation 18FDG-PET image outcome predictions with breakdown biological components for enhanced explainability. The proposed method was developed using 64 oropharyngeal patients with paired 18FDG-PET studies before and after 20-Gy delivery (2 Gy/day fraction) by intensity-modulated radiotherapy (IMRT). In a two-branch deep learning execution, the proposed CNN learns specific terms in the biological model from paired 18FDG-PET images and spatial dose distribution in one branch, and the biological model generates post-20-Gy 18FDG-PET image prediction in the other branch. As in 2D execution, 718/233/230 axial slices from 38/13/13 patients were used for training/validation/independent test. The prediction image results in test cases were compared with the ground-truth results quantitatively.Results: The proposed method successfully generated post-20-Gy 18FDG-PET image outcome prediction with breakdown illustrations of biological model components. Standardized uptake value (SUV) mean values in 18FDG high-uptake regions of predicted images (2.45 ± 0.25) were similar to ground-truth results (2.51 ± 0.33). In 2D-based Gamma analysis, the median/mean Gamma Index (<1) passing rate of test images was 96.5%/92.8% using the 5%/5 mm criterion; such result was improved to 99.9%/99.6% when 10%/10 mm was adopted.Conclusion: The developed biologically guided deep learning method achieved post-20-Gy 18FDG-PET image outcome predictions in good agreement with ground-truth results. With the breakdown biological modeling components, the outcome image predictions could be used in adaptive radiotherapy decision-making to optimize personalized plans for the best outcome in the future.

22 March 2023 in Frontiers in Oncology
Verified
Journal Article
Open access
WHWilliam Thomas Hrinivich
William Thomas Hrinivich
TWTonghe Wang
Tonghe Wang
CWChunhao Wang
Chunhao Wang
Editorial: Interpretable and explainable machine learning models in oncology